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Lymphoid cells with the ability to lyse certain tumor cell lines in vitro without 
prior deliberate immunization collectively have been designated "natural killer" 
(NK) 1 cells.  In  man,  these cells have been identified by morphological  criteria 
(1-3)  and  by the  presence  of certain  cell  surface  antigens  (4-13).  Recently, 
several investigators have reported that cells isolated from allogeneic or autolo- 
gous mixed lymphocyte responses (MLR) also can demonstrate "NK-like" activity 
(14-21). These cells do not express certain antigens associated with cytotoxic T 
cells  (e.g.  Leu-4(T3))  and  do  not  demonstrate  antigen  specificity against  the 
immunizing  cell population (14-21).  Furthermore,  they do not express certain 
antigens that previously have been used to identify resting peripheral blood NK 
cells, such as Leu-7 and OKM 1 (14, 15). Thus, although cells with the functional 
properties of NK cells are present in MLR cultures, positive identification and 
isolation of these cells has proven difficult without a  specific marker  for these 
cells. 
Recently, we have described a monoclonal antibody, anti-Leu-1 1, which reacts 
with essentially all  NK cells in  normal  human  peripheral  blood (4,  5).  In  this 
study, we have examined whether or not the anti-Leu-1 1 antibody would react 
with NK cells present in an allogeneic MLR. Our findings indicated that it was 
possible to identify and isolate these NK-like cells using the anti-Leu-11 antibody. 
A  detailed study of the MLR-activated Leu-1 1+ cells indicated that a  subset of 
these  NK  cells demonstrated  enhanced  NK  cytotoxic function  and  expressed 
"activation" related antigens, such as DR, DC, and transferrin  receptor on their 
cell surface, 
Materials and Methods 
Preparation of Human Peripheral Blood Leukocytes.  The cell fraction of plasmaphoresed 
human peripheral blood from normal donors was obtained from the American Red Cross, 
San Jose, CA. The mononuclear cells were isolated from Ficoll/Hypaque (Pharmacia Fine 
Chemicals, Piscataway, N  J) by standard methods. The isolated cells were washed twice in 
large volumes of sterile phosphate-buffered saline (PBS, 0.1 M phosphate, pH 7.3). 
Abbreviations used in this paper:  ADCC,  antibody-dependent  cellular cytotoxicity;  AMLR,  autolo- 
gous mixed lymphocyte  response; C', complement; E/T, effector/target; FITC, fluorescein  isothio- 
cynate; HBSS, Hank's balanced salt solution; LGL, large granular lymphocyte; MHC, major histo- 
compatibility complex; NK, natural killer; PE, phycoerythrin; PBS, phosphate-buffered  saline. 
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TABLE  I 
Specificity of Monodonal Antibodies 
Monoclonal antibody  Specificity 
Leu-2a 
Leu-3a 
Leu-4 
Leu-7 
Leu-10 
Leu-1 la & Leu-1 lb 
DR (clone L243) 
Transferrin receptor 
(clone L01.1) 
Suppressor/cytotoxic T cell subset and NK sub- 
set 
Helper/inducer T cell subset and monocytes 
T lymphocytes 
HNK-1 antigen;  large granular lymphocytes 
and subset of NK cells 
HLA-DC, a polymorphic antigen absent on 
DR7 homozygous cells 
Fc receptor of large granular lymphocytes, NK 
cells, and neutrophils 
HLA-DR, monomorphic determinant 
Human transferrin receptor 
Reagents.  All monoclonal antibodies used in these studies were prepared at the Becton 
Dickinson  Monoclonal Center,  Inc.  The anti-Leu-1 la  monoclonal antibody is derived 
from the hybridoma NKP-15 (2, 4, 5) and the anti-Leu-1 lb monoclonal antibody from 
clone G022 (22). The anti-human transferrin receptor monoclonai antibody was produced 
by  clone  L01.1.  This  hybridoma  was  generated  by  immunizing  BALB/c  mice  with 
pokeweed  mitogen-activated  human  lymphoblasts and  fusing the  immune  spleen  cells 
with  the  P3X-Ag8-8463 myeloma line.  The monoclonal antibody reacts with activated 
lymphocytes, monocytes, and tumor cell lines and immunoprecipitates a two-chain disul- 
fide-linked molecule with a  90-kd (reduced) and  180-kd (unreduced)  molecular weight. 
The antibody also immunoprecipitates complexes of ~'5I labeled Fe-saturated transferrin/ 
transferrin receptor from cells incubated in the presence of ~SI-labeled transferrin.  The 
specificity of all monoclonal antibodies used in this study are presented in Table I. 
Two-Color Immunofluorescence Staining.  Immunofluorescence staining was performed as 
described in detail elsewhere (23). Isotype-matched fluorescein isothiocyanate (FITC) or 
phycoerythrin-conjugated monoclonal antibodies or myeloma proteins that did not spe- 
cifically react with human cells were used to control for Fc-related bindings. All dilutions 
and  cell  washing  were  performed  in  cold  PBS  containing  0.1%  sodium  azide  and  all 
procedures were carried out at 4°C. 
Two-Color Flow  Cytometry.  Two-color  immunofluorescence  experiments  were  per- 
formed as described previously (23). Fluorescein and phycoerythrin were excited using a 
single argon ion laser (488  nm,  200  mW).  Dead cells,  erythrocytes, and platelets  were 
excluded from analysis by setting an appropriate  threshold  trigger on the  low forward 
angle and 90 ° light scatter parameters. Low angle forward light scatter, 90 ° light scatter, 
green fluorescence, and red fluorescence signals were stored in list mode data files using 
a Consort 40 PDP/11  based computer system (Becton Dickinson FACS division, Sunny- 
vale,  CA).  Two-parameter data  were collected into a  64  x  64 matrix  and displayed as 
contour maps. "Contours" were drawn to indicate increasing numbers of cells in a defined 
area  of the  array.  Areas  within  the  contour  map  were  integrated  to  determine  the 
percentage of cells. These methods of analysis have been described previously (23). 
Cytotoxicity Assay.  Human tumor cells were labeled with 5~Cr and were used as targets 
in a 4-h radioisotope release cytotoxicity assay as described previously (23). 
Sensitizer Cells.  10-20  X  108  CCRF-SB allogeneic  tumor  cells  were  incubated  with 
mitomycin C (80 ~g/ml) in serum-free RPMI- 1640 media for 1 h at 37 ° C. After incubation 
the  tumor cells  were  washed  three  times  in  Hank's balanced salt  solution  (HBSS) and 
resuspended at a  concentration of 1 x  10  ~ cell/ml  in  RPMI-1640 containing 5%  heat- 
inactivated horse serum, 2 mM glutamine, and antibiotics. 
Allogeneic MLR.  Responder lymphocytes were suspended in RPMI-1640 media con- PHILLIPS  ET  AL.  995 
taining 5% heat-inactivated horse serum, glutamine, and antibiotics at a concentration of 
1 ×  106 cells/ml. Responder cells (10 x  106) were mixed with stimulator cells (10 x  106) 
in a total volume of 10 ml media in T25 tissue culture flasks (Falcon Plastics, Oxnard, 
CA). The flasks were incubated in an upright position in a humidified 5% CO2 atmosphere 
at 37°C for 5 d. On the fifth day the cells were harvested, washed in HBSS, and viable 
cells isolated by centrifugation on Ficoll/Hypaque (Pharmacia Fine Chemical). 
Complement-mediated Cytotoxic Depletions.  Peripheral  blood lymphocytes or MLR-gen- 
erated cells were sensitized with primary antibodies (anti-Leu-1, anti-Leu-7, or anti-Leu- 
1  lb) at optimal concentrations  for 45  min at room temperature. The cells were then 
centrifuged, the supernatant removed, and a pretitered optimal amount of  neonatal rabbit 
complement added to the cells. The cells were then incubated at room temperature for 1 
h with occasional agitation.  After incubation  the cells were washed twice in HBSS and 
incubated an additional 20 min at 37°C to allow for dead cells to break part. The viable 
cells were then isolated by centrifugation on Ficoll/Hypaque. 
Morphology.  Aliquots of cell suspensions were cytocentrifuged onto ethanol-cleaned 
glass slides. The slides were fixed in absolute methanol for 10 min and rapidly air dried. 
The fixed cells were then stained in a  10% aqueous solution of Giemsa for 10 min and 
washed in distilled water.  Light microscopic analysis was performed by oil immersion 
microscopy according to standard morphological criteria. 
Results 
Phenotypic Analysis of Cells in Allogeneic MLR and Control Cultures.  An allogeneic 
MLR was generated by co-culturing human peripheral blood mononuclear cells 
with a  mitomycin C-treated allogeneic B  lymphoblastoid cell line,  CCRF-SB. 
The responder cells generated in 5-d allogeneic mixed lymphocyte cultures and 
control cultures (i.e., peripheral blood mononuclear cells cultured in the absence 
of a stimulator cell population) were examined by multi-parameter flow cytom- 
etry. Based on low forward angle and 90-degree light scatter profiles, -60% of 
cells  in  the  MLR  culture  were  large  lymphoblasts,  whereas  control  cultures 
showed few lymphoblasts (<5%).  The majority of the MLR-activated lympho- 
blasts expressed the Leu-4 and Leu-2 surface antigens, as would be expected in 
a  vigorous T  cell  specific in  vitro immune response.  However,  ~15%  of the 
MLR-generated lymphoblasts expressed  the  Leu-11  antigen, a  marker that is 
present on essentially all cytotoxic NK cells in normal human peripheral blood 
(4,  5,  23).  Similar to the  Leu-11+  lymphocytes present  in  normal peripheral 
blood and in control cultures, the Leu-11 +  lymphoblasts did not co-express the 
pan T  cell antigen, Leu-4, or the helper/inducer T  cell subset marker Leu-3 
(Fig. 1). However, ~25% of the Leu-11+ lymphoblasts did co-express Leu-2a in 
low cell surface density (Fig. 1). Leu-2a is expressed on the cytotoxic/suppressor 
T  lymphocyte subset and on a  subpopulation of normal resting Leu-11+  NK 
cells (23).  Leu-11+ MLR-generated NK cells did not co-express Leu-M3 (mon- 
ocyte antigen) or Leu-7, an antigen expressed on a  large percentage of normal 
peripheral blood NK cells (13). A small percentage (~3%) of the MLR-generated 
lymphoblasts, however, did express the phenotype, Leu-4+,Leu-7+,Leu-11-. 
The most striking difference between control and MLR-generated Leu-11+ 
cells was the co-expression of Leu-11 and Class  II MHC antigens on the MLR- 
generated cells (Fig. 2). DR and DC(Leu-10) antigens were co-expressed on the 
MLR-generated Leu-11 +  cells,  but not on a significant percentage of Leu-11+ 
cells in freshly isolated human mononuclear cells or in control cultures (<2%). 
Since the SB cell line used as stimulator expressed both DR and DC antigens, it 996  MIXED  LYMPHOCYTE  RESPONSE-ACTIVATED  HUMAN  NK  CELLS 
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FIGURE  1.  Two-color flow cytometric analysis of co-expression of Leu-11 with Leu-2, Leu- 
3, and Leu-4 on ailogeneic MLR-activated lymphoblasts. Viable cells were isolated from a 5-d 
MLR  culture  generated  by  co-culture  of human  peripheral  blood  mononuclear  cells and 
mitomycin C-treated CCRF-SB cells. Cells were stained with: FITC anti-Leu-I 1 and PE anti- 
Leu-4 (upper right); FITC anti-Leu-I 1 and  PE anti-Leu-3  (lower left); FITC anti-Leu-11 
and PE anti-Leu-2 (lower right); and FITC and PE conjugated isotype controls (upper left). 
Samples were analyzed  using a  FACS 440  system  as described  in  Materials and  Methods. 
Correlated green (x axis, log scale) and red fluorescence (y axis, log scale) on the lymphoblasts 
are presented as contour plots. Based on the control sample, the contour plots were divided 
into four quadrants:  I,  Cells with red fluorescence only; H, ce]ls  with both  red and  green 
fluorescence; lli,  unstained cells; and/V, cells with green fluorescence only. The number of 
cells within each of these areas was integrated and the percentage of the total number of cells 
analyzed,  determined.  The  expression  of  Leu-11  with  Leu-4  and  Leu-3  was  essentially 
nonoverlapping (e.g. Leu-4+, 11 +, <2% of lymphoblasts; Leu-3+, 11 +, <2% of lymphoblasts). 
However, 4% of lymphoblasts were phenotyped Leu-2+, 11 +  and  12%  of lymphoblasts were 
Leu-2-, 11 +. 
was  possible  that  the  Leu-ll+  lymphoblasts  passively  acquired  DR  and  DC 
antigens that  had been shed from the B  cell line.  To exclude this possibility, 
MLR  were  generated  using  a  DR7  homozygous B  lymphoblastoid cell  line, 
Mann, which was genetically negative for the Leu-10 DC antigen. Results from 
these experiments again  showed that the  Leu-11+  lymphoblasts co-expressed 
both DR and DC antigens. This conclusively demonstrated that the DC antigen 
was not passively acquired from the stimulator cell line. Further evidence for a 
qualitative change in the Leu-11 +  cells was the presence of transferrin receptor 
on the surface membrane of the MLR-activated, but not resting, Leu-11 +  cells 
(not shown). 
Cytotoxic Potential of Allogeneic MLR and Control Cultures.  The cytotoxic capa- 
bilities and specificities of cells isolated from 5-d MLR and control cultures were 
examined using a  4-h 51Cr release assay against the sensitizing tumor cell line, 
CCRF-SB,  and the NK-sensitive target cell line,  K562.  Low levels of NK cell 
cytotoxicity against K562 were observed in control cultures, whereas cytotoxicity PHILLIPS  ET  AL.  997 
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FIGURE 2.  Two-color flow cytometric analysis of co-expression of Leu-11 with class II MHC 
antigens on MLR-activated lymphoblasts and control culture lymphocytes. Viable cells isolated 
from 5-d MLR (panels A-C) or control (panels D-F) cultures were stained with: FITC anti- 
Leu-11 and PE anti-DR (center panels); FITC anti-Leu-I 1 and PE anti-DC(Leu-10) (right 
panels); or FITC and PE isotype controls (left panels). Samples were analyzed with a FACS 
440 system as described in Material and Methods. Data are presented as described in Fig. 1 
legend.  Note  that  a  large  percentage  of the  Leu-ll+  MLR-generated  lymphoblasts co- 
expressed DR and DC antigens (Leu-1 I+,DR+  11%  of lymphoblasts; Leu-11+,DR- 5% of 
lymphoblasts; Leu-11+,DC+ 10%  of lymphoblasts; Leu-1 I+,DC-6% of lymphoblasts; Leu- 
11-,DR+ 50% of lymphoblasts; and Leu-11-,DC+ 40% of lymphoblasts). In contrast, few 
Leu-11+ cells in the control cultures co-expressed DR or DC antigens (Leu-1 I+,DR+ <1% of 
lymphoid cells;  Leu-11+,DC+ <1% of cells;  Leu-1 I+,DC- 7% of cells; and Leu-1 l+,DR- 
8% of cells). 
against the NK-resistant cell line, CCRF-SB, was essentially nonexistent (Fig. 3). 
Analysis of the cell-mediated cytotoxicity potential of the MLR-generated cells 
showed substantially elevated levels of cytotoxicity against CCRF-SB, as well as 
augmented levels of cytotoxicity against the NK-sensitive tumor cell line K562 
(Fig. 3). Treatment of MLR cultures with the pan T  cell monoclonal antibody, 
anti-Leu-1,  and complement essentially eliminated the  cytotoxicity generated 
against the sensitizing tumor cell line, CCRF-SB, without diminishing cytotoxicity 
against K562 (Fig. 4). In striking contrast to the elimination of the specific T  cell 
response  with  anti-Leu-1  and  complement,  treatment  of MLR  cultures with 
anti-Leu-1 lb and complement severely depleted cytotoxicity against K562, but 
not CCRF-SB. Thus, essentially all "NK-like" cytotoxicity activity was contained 
within the small population of cells expressing the Leu-11 antigen, but not the 
Leu-1 antigen. 
Functional Analysis of the Leu-I I +,DR+ Subpopulation.  Functional studies of 
the  MLR-generated effector cells clearly indicated that  the cytotoxicity mani- 
fested against K562 was primarily mediated by effector cells expressing the NK 
cell-associated surface antigen Leu- 11. Phenotypic analysis of the Leu- 11 +  cells 
in these MLR cultures showed that a  majority of these cells also co-expressed 998  MIXED  LYMPHOCYTE  RESPONSE-ACTIVATED  HUMAN  NK  CELLS 
=  *  MLR 
o---o  Control 
>,  8O 
"~  70 
"~  60 
~  50 
(,~  4o 
~ ao 
~.  20 
10 
A 
50  25  12  6 
E/T Ratio 
B 
50  25  12  6 
E/T Ratio 
FIGURE 3.  Cell-mediated cytotoxicity of MLR and control cultures. Lymphoid cells gener- 
ated in a 5-d allogeneic MLR against CCRF-SB (0) and lymphocytes from control cultures (O) 
were assessed for cytotoxic activity in a 4-h 51Cr release assay.  K562 and CCRF-SB tumor cell 
lines were used as targets. The results are expressed as percent specific cytotoxicity vs. effector/ 
target ratio (E/T). 
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FIGURE 4.  Cell-mediated  cytotoxicity of MLR  cultures  depleted  of Leu-l+  or  Leu-11+ 
effector cells. Lymphoid cells generated in a  5-d MLR against CCRF-SB were treated with 
complement (C') alone (O), with anti-Leu-1  and C' (0), or anti-Leu-1 lb and C' (A) before 
being assayed for cytotoxic activity in a 4-h SlCr release assay against K562 (A) and CCRF-SB 
(B) at varied E/T ratios. PHILLIPS ET  AL.  999 
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FIGURE 5.  Two-color cell sorting of Leu-II+,DR+ and Leu-ll+,DR- MLR-generated 
lymphoblasts.  Viable lymphoid cells isolated from a 5-d MLR culture against CCRF-SB  tumor 
cells were stained with: FITC anti-Leu-11 and PE anti-DR monoclonal  antibodies. Cells were 
analyzed using a FACS 440 system as described in Materials and Methods. The profiles of 
Leu-ll  (green) and  DR (red) fluorescence are  presented. The gain controls on the  log 
amplifiers were adjusted to optimize separation of the four populations. Control cells, stained 
with isotype-matched  FITC and PE myeloma proteins, were all present in quadrant I (not 
shown). Sorting windows  were set on the Leu-11+,DR+ cells  (quadrant//) and Leu-1  I+,DR- 
cells (quadrant/V). Re-analysis  of the sorted populations indicated that each population was 
>95% pure. 
DR and DC antigens. Since the expression of class II MHC gene products on 
Leu-11+ NK cells appears to be a  direct result of the MLR conditions, experi- 
ments  were  performed  to  determine  whether  this  phenotypic  alteration  was 
accompanied by change in  functional capacity. Cells from a  5-d  MLR culture 
were stained simultaneously with FITC anti-Leu-1 la and PE anti-DR monoclo- 
hal antibodies for two-color immunofluorescence analysis. As indicated in Fig. 
5,  the  Leu-1 I+,DR+  and Leu-1 I+,DR-  subpopulations were  isolated to 95% 
purity by using two-color cell sorting with a  fluorescence-activated cell sorter. 
The cytotoxic activities of the sorted subpopulations against K562 are presented 
in Fig. 6. The results of these experiments demonstrated that on a per-cell basis 
the  Leu-1 I+,DR+  cells were  more  efficient cytotoxic effectors than the  Leu- 
11 +,DR-  cells, although both mediated significant cytotoxicity against K562. 
Examination of Giemsa-stained preparations of the sorted subpopulations by 
light microscopy indicated that the Leu-11 +,DR-  cells were a  relatively homo- 
geneous population of large granular lymphocytes with prominent azurophilic 
granules  (Fig.  7).  The  morphology of the  Leu-ll+,DR-  cells  was  essentially 
identical to the morphology of large granular lymphocytes (LGL) isolated from 
fresh peripheral blood. The Leu-11 +,DR+ cells, however, were morphologically 
heterogeneous. ~70 % of the Leu-11 +,DR+ cells were large agranular lymphoid 
cells with prominent vacuoles and lobular euchromatic nuclei, 20%  of the cells 1000  MIXED  LYMPHOCYTE  RESPONSE-ACTIVATED  HUMAN  NK  CELLS 
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FIGURE 6.  Cell-mediated cytotoxicity of Leu-1 I+,DR+ and Leu-11+,DR- cells. The Leu- 
1 I+,DR+ and Leu-1 I+,DR- cells were purified from a 5-d MLR culture against CCRF-SB 
tumor by two-color FACS cell sorting as described in Fig. 5. Cell-mediated cytotoxicity was 
assessed in a 4-h SlCr release assay against K562 tumor cells. Note that the cytotoxic potential 
of the Leu-11 +,DR+ cells was substantially greater than the Leu-11 +,DR- cells, particularly 
at the lower E/T ratios, and that both subsets demonstrated more cytotoxic activity than the 
antibody-stained, unsorted control cells. 
FIGURE 7.  Light microscopic morphology of Leu-11+,DR+  and  Leu-I I+,DR  cells.  The 
Leu-11+,DR+ (A) and Leu-11+,DR- (B) subsets purified by two-color FACS cell sorting as 
described in  Fig.  5  were  stained  with  Giemsa.  Note  that  the  Leu-ll+,DR-  cells  are  a 
homogeneous population of typical LGL, whereas the Leu-I I+,DR+ cells are more hetero- 
geneous with numerous agranular blasts, and mitotic configurations. Giemsa stain, × 4,000. 
displayed typical  LGL  morphology,  and  10%  of the  Leu-ll+,DR+  cells were 
typical mitotic configurations. 
Analysis of the Peripheral Blood Precursor of the MLR-generated NK Cells.  Studies 
to  determine  the  precursor  of the  Leu-11+  NK  cell in  the  MLR  culture  were 
undertaken  using depletion of Leu-7+  or Leu-11+  cells before the initiation of 
the MLR  cultures.  Treatment  of the responder  cell population with anti-Leu-7 
and  complement  had  no  effect  on  the  subsequent  MLR-induced  generation  of 
Leu-11+,DR+  NK cells (Fig. 8).  However,  depletion of Leu-11+  cells from  the 
responder  population  with anti-Leu-1 lb  and complement  before  MLR  culture PHILLIPS  ET  AL.  1001 
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FIGURE 8.  Cell-mediated cytotoxicity of MLR cultures depleted of Leu-7 or Leu-11 positive 
lymphocytes before MLR. Peripheral blood mononuclear cells were treated with complement 
alone, anti-Leu-7 and complement, or anti-Leu- 11 b and complement before the MLR culture. 
Viable cells from 5-d MLR cultures against CCRF-SB were assessed for cell-mediated cytotox- 
icity in a 4-h 51Cr release assay against K562 at an E/T of 25:1. Note that only depletion with 
anti-Leu-1 lb before the MLR culture significantly diminished the generation of cytotoxic 
cells for K562 target cells. 
prevented the generation of Leu-11 +  cells and appreciable levels of cytotoxicity 
against K562 (Fig. 8). The results clearly indicated that the MLR-generated Leu- 
1 I+,DR+  subset originated from Leu-11+ precursors, which lacked the Leu-7 
antigen. 
Discussion 
Co-culture of human peripheral blood mononuclear cells with an allogeneic 
tumor cell  can  result  in  the  proliferation  of certain  T  lymphocytes and  the 
activation of T  lymphocytes with the capacity to lyse the tumor. Many of these 
cytotoxic T  lymphocytes demonstrate exquisite specificity for the immunizing 
tumor cell line. Although exceptions have been noted, in general, cytotoxic T 
cells generated against a histoincompatible class I major histocompatibility com- 
plex (MHC) target express the pan T  cell antigen,  Leu-4 (T3), and the Leu-2 
(T8) subset marker (24-28).  It has been observed that other lymphoid cells in 
the MLR culture are cytotoxic, yet are not specific for the immunizing cell. Since 
some of these cells demonstrate functional properties similar to natural  killer 
cells, they have been deemed "NK-like"  cells (14-21).  These cells occur in low 
frequency in the MLR culture, and there have been few markers that permit 
isolation of these cells for phenotypic and functional studies. 
Recently, we have described a monoclonal antibody, anti-Leu-11, which reacts 
with NK cells in human peripheral blood (4,  5).  This antibody recognizes an 
antigen, associated with the  Fc receptor for  IgG,  that is present on  LGL and 
neutrophils (4, 5).  Leu-11  antigen is not present on resting monocytes, eosino- 
phils,  B  lymphocytes, and  most  mature  T  lymphocytes expressing the  Leu-4 
antigen (4, 5). Similar antibodies have been described by other investigators (7- 
9).  Essentially  all  cytotoxic  NK cells and  cells capable  of mediating antibody- 
dependent  cellular  cytotoxicity  (ADCC)  in  human  peripheral  blood  can  be 
isolated using anti-Leu-11 antibody (4, 5, 23). Preliminary reports by Thompson 
and co-workers (22) indicated that NK cells present in a MLR culture could be 
eliminated by treatment with the anti-Leu-1 lb and complement. 1002  MIXED  LYMPHOCYTE  RESPONSE-ACTIVATED  HUMAN  NK  CELLS 
In these studies, we have addressed the question of whether or not Leu-11 
antigen is present on the "NK-like" cells present in a  MLR culture generated by 
co-culture of human peripheral  blood mononuclear cells and an allogeneic B 
iymphoblastoid cell line (CCRF-SB). Whereas CCRF-SB specific cytotoxic T  cells 
generated in these cultures did not express the Leu-11 antigen, anti-Leu-11 and 
complement treatment removed most "non-specific" cytotoxicity against the NK- 
sensitive target cell K562.  In contrast, anti-Leu-1  and complement eliminated 
CCRF-SB specific cytotoxic T  cells, but not K562 "NK-like" cytotoxic effectors. 
Hence,  Leu-11  provided  the  specific  probe  needed  to  isolate  these  unique 
cytotoxic cells for study of their function, phenotype, and morphology. 
How do these MLR-activated "NK-like" cells relate to NK cells freshly isolated 
from peripheral blood? In a  series of experiments using multicolor immunoflu- 
orescence and flow cytometric analysis, the cell surface antigen profile of NK 
cells was examined in detail (5, 23, 29). Studies of both Percoll gradient-purified 
LGL (29) and Ficoll-Hypaque-isolated peripheral blood mononuclear cells (23) 
indicated that within the population of Leu-11-positive cells, considerable het- 
erogeneity  exists  with  regards  to  expression  of other  surface  antigens.  For 
example, using a combination of both anti-Leu-2 and anti-Leu-11  for two-color 
immunofluorescence, four populations can be defined in some individuals, i.e. 
Leu-2+,l 1+; Leu-2+,l 1-; Leu-2-11+; and Leu-2-,11- (23). Functionally, the 
Leu-2+,ll+  and  Leu-2-,ll+  populations  were  equally  efficient  and  potent 
mediators of cytotoxicity against  K562.  Leu-2+,ll+,  NK  cells differed  from 
Leu-2+ T  cells, in that the Leu-2+, 11 +  cells did not co-express the pan T  cell 
markers, Leu-1 and Leu-4 (23). Additionally, the quantity of Leu-2 antigen on 
the NK cell population was significantly less than on the Leu-2+,4+ T  cell subset 
(23). Perussia and co-workers (30) also have demonstrated the existence of a low 
density Leu-2+,4- NK cell subset. 
Similarly to the freshly isolated Leu-11+ cells, MLR-activated Leu-11+ cells 
did not co-express T-associated antigens, Leu-1, Leu-3 or Leu-4, and did not co- 
express Leu-M3, a marker of mature monocytes. A proportion of MLR-derived 
NK  cells  were  observed  to  co-express  low  cell  surface  density  of the  Leu-2 
antigen. Similar studies by Lopez-Botet et al.  (16) have indicated that the NK- 
like cells within a mixed lymphocyte response culture lacked the T cell-associated 
antigens, T4 (Leu-3) and T8 (Leu-2). Strassman et al. (I 4) also have demonstrated 
that MLR-activated NK cells do not express T3 (Leu-4) or T8 (Leu-2). 
Recently,  we  have  reported  that  in  freshly  isolated  peripheral  blood  four 
discrete subpopulations can be identified using the anti-Leu-7 and anti-Leu-11 
monoclonal antibodies in two-color immunofluorescence (i.e., Leu-7-, 11-; Leu- 
7-,11+;  Leu-7+,l 1+; and Leu-7-,11-) (23). Functionally, the Leu7-,11+ cell 
demonstrated that most cytotoxicity against K562  on a  per-cell basis,  whereas 
the Leu-7+, 11 + and Leu-7+, 11- generally were less efficient (23). The majority 
of the Leu-7+, 11 -  cells, which demonstrate weak cytotoxic activity, co-expressed 
the pan T  cell antigen Leu-4 and high cell surface density of Leu-2 antigen (23). 
Abo and co-workers (31)  similarly have shown that the  Leu-7  subset that  co- 
expressed  Leu  4  (T3)  is an  inefficient cytotoxic effector.  Based on  ontogeny 
studies, these investigators suggested that this phenotype may reflect "pre-NK" PHILLIPS  ET  AL.  1003 
cells (32). In the MLR cultures, few Leu-11+ cells co-expressed Leu-7, however, 
a small population of Leu-4+,7+ cells were present. 
The most significant difference between freshly isolated Leu-11 + cells and the 
MLR- activated Leu-11+ cells was the presence of class II MHC gene products 
on a significant proportion of the MLR-derived Leu-11 +  cells. The majority of 
freshly isolated Leu-11+ cells did not express DR or DC (Leu-10) antigens, as 
determined by two-color immunofluorescence. However, after MLR activation, 
Leu-11 + cells that co-express DR and DC were evident. The Leu-11 +,DC+ cells 
did not passively acquire DC  antigens from the stimulating B  lymphoblastoid 
cells, since Leu-11 +,DC+ cells were present in MLR cultures generated using a 
genetically DC-negative B cell line. Furthermore, co-culture of peripheral blood 
mononuclear cells  depleted  of the  DR+,DC+  monocytes and  B  cells  with  a 
genetically DC-negative B cell line did not prevent generation of Leu-11+ cells 
that  co-expressed DR  and  DC  (unpublished observation).  These  experiments 
suggest that synthesis of the class II molecules was induced as a consequence of 
the MLR.  Biosynthetic labeling studies will be required to definitively confirm 
this. It should be noted that Ortaldo and co-workers (6, 33) have reported that 
a proportion of Percoll gradient-isolated LGL react with an anti-DR monoclonal 
antibody.  Although  we  have  occasionally  observed  individuals  with  Leu- 
1 I+,DR+  cells, this was not the general situation.  Perhaps this discrepancy is 
due to differences in blood preparation or the specificity of the anti-DR antibod- 
ies. Nonetheless, we have clearly shown that a significant increase in the propor- 
tion  of Leu-11+  cells that  co-express DR  and  DC  is a  consequence of MLR 
culture. Whether this represents de novo synthesis of class II MHC gene products 
or expansion of a  small  Leu-1 I+,DR+  cell present in effector cell population 
before generation of the MLR is under study. Further evidence for phenotypic 
alteration  resulting  from  MLR  activation  was  the  appearance  of  Leu-ll+, 
transferrin receptor+  cells.  Resting  Leu-11+  cells did not express  detectable 
levels of transferrin receptor. The induction of increased levels of transferrin 
receptor has been shown to he an indicator of cell activation (34). 
What is the significance of the presence of DR and DC antigens on  MLR- 
activated NK cells? Two-color cell-sorting experiments definitively showed that 
on a per-cell basis that MLR-activated Leu-11 + lymphoid cells that co-expressed 
DR antigens were more efficient killers of K562  targets than the DR-negative 
Leu-11+ population.  Therefore, the phenotypic change in the MLR-activated 
cells appears to correlate directly with a  change in cell function. In a  study of 
NK cells present in an autologous MLR culture, Goto and Zvaifler (15) showed 
that  treatment with anti-DR  and  complement partially reduced the cytotoxic 
activity of AMLR cells against the NK-sensitive target K562,  indicating that a 
subset of the NK cells must express this marker. 
The induction of class I I MHC gene products as a consequence of cell activation 
has been observed for both T  cells and monocytes. Human peripheral blood T 
lymphocytes, which do not express DR or DC antigens, acquire these glycopro- 
teins during MLR culture (34, 35). Studies by Basham and co-workers (3fi) have 
shown increased levels of class II gene products on human monocytes after co- 
culture with interferon. In the mouse, biosynthesis and expression of Ia antigens 
can be induced on macrophages (37, 38) and macrophage tumor cell lines (39- 1004  MIXED  LYMPHOCYTE RESPONSE-ACTIVATED HUMAN NK  CELLS 
41). Recent studies have indicated that gamma interferon mediates the induction 
of Ia protein synthesis in macrophages (42). Whether or not gamma interferon 
is responsible for induction of DR and DC on MLR-activated NK cells is under 
investigation.  The induction of Ia antigen expression on murine macrophage 
cell lines was shown to be associated with the ability of these cells to efficiently 
function in antigen presentation (39, 40). Similarly, expression of class II MHC 
molecules on  human  monocytes is  thought  to  influence antigen presentation 
(43). Since human NK cells share many common properties with monocytes, the 
ability of DR-positive NK cells to present antigen should be considered. 
The morphological characteristics of human NK cells have become a  useful 
and widely accepted marker of this cell population. Light microscopic studies of 
human NK cells purified from peripheral blood on Percoll gradients have shown 
that  these  cells  are  "large  granular  lymphocytes" (1,  2).  Likewise,  Leu-ll+ 
lymphocytes isolated from freshly isolated peripheral blood mononuclear cells 
demonstrated  typical  LGL  characteristics  (4).  The  morphology of the  Leu- 
11 +,DR- cells from MLR cultures was consistent with the LGL morphological 
classification.  The  Leu-1 I+,DR+  cells  were more  heterogeneous, containing 
typical LGL, numerous agranular lymphoblasts, and a significant proportion of 
mitotic configurations. The existence of lymphoblastoid cells, as well as mitotic 
figures in the Leu-11 +,DR+ subset clearly demonstrates MLR-induced activation 
of this NK cell population.  Thus, the morphological heterogeneity of the Leu- 
11 +,DR+ subset may reflect the various phases of the activation/mitotic cycle 
of the Leu-11+ NK cells. 
If the MLR-activated Leu-11 +,DR+ cells are a member of the NK lineage(s?), 
what is their direct precursor in the peripheral blood? Depletion studies indicated 
that  removal  of Leu-11+  cells  from  the peripheral  blood  mononuclear cells 
before  co-culture  with  the  SB  target  cell  prevented  generation  of the  Leu- 
11 +,DR+ subset. In contrast, removal of Leu-7 cells before establishment of the 
MLR culture did not effect the subsequent generation ofcytotoxic Leu-11 +,DR+ 
ceils. Furthermore, elimination of the Leu-7 cells present in the MLR culture 
neither enhanced nor diminished specific cytotoxic activity against the B  lym- 
phoblastoid cells used as the stimulator. These data suggest that the Leu-7 cells 
in the MLR do not serve as specific cytotoxic cells or act as suppressors of the 
cytotoxic T  cells. These studies are in agreement with Abo and co-workers (44) 
who have reported that NK-like cells in a MLR did not arise from Leu-7-positive 
precursors. Thus, these cells must arise from a Leu-7-, 11 +  precursor. Further 
studies will be required to establish whether or not the Leu-7-, 11 + cell develops 
from the Leu-7+, 11 + or Leu-7+, 11- populations or rather arises from a distinct 
precursor. 
Strassmann  and  co-workers  (14)  have  observed  that  the  peripheral  blood 
precursor of the MLR-activated NK cells reacted with the OKM1  and B73.1 
monoclonal antibodies. However, the activated NK cell generated after the 5-d 
MLR culture did not express the OKM 1 or B73.1  antigens. This is noteworthy 
since the anti-Leu-I 1 and B73.1  monoclonal antibodies both react with essen- 
tially all NK cells in freshly isolated peripheral blood and give essentially identical 
immunofluorescence staining patterns  with  large granular lymphocytes, when 
analyzed using quantitative flow cytometric analysis (Lanier, unpublished obser- PHILLIPS ET AL.  1005 
vation).  Similarly, both  antibodies inhibited  the binding of IgG complexes to 
large granular lymphocytes, suggesting that these antibodies react with a deter- 
minant near  the  Fc  receptor of large granular  lymphocytes (4,  5,  7,  8,  23). 
However, B73.1  differs from  Leu-ll  in  that  B73.1  is  unreactive with  MLR- 
activated NK cells (14) and is only weakly reactive with neutrophils (7,  8).  In 
contrast,  Leu-11  is present on the majority of MLR-activated NK cells and is 
present in  high  cell  surface density on neutrophils  (4,  5,  23).  The structural 
difference in the Leu-11 and B73.1  antigens is currently under investigation. 
An important question is whether or not the Leu-11 +,DR+ cells play a role in 
vivo in response to infectious disease or malignancy. As a practical sequence of 
these studies,  the combined use of anti-Leu-11  and anti-class  II  monoclonal 
antibodies provides a convenient way to assess  the role of these "activated" NK 
cells in the clinical research laboratory. Study of the presence and function of 
these cells in transplant recipients and patients undergoing therapy with immu- 
nomodulators known to affect NK cells such as interferon and interleukin 2 may 
allow us to better understand the physiological role of these cells. 
Summary 
Lymphoid cells with natural killer (NK)-like function, morphology, and anti- 
genic phenotype have been identified in a mixed lymphocyte culture generated 
by co-culture of human peripheral blood mononuclear cells with an allogeneic 
human  B  lymphoblastoid  cell  line  CCRF-SB.  The  majority  of these  mixed 
lymphocyte (MLR)-response activated NK cells express the Leu-11 surface anti- 
gen, but do not express certain T  cell-associated antigens (Leu-1,  Leu-3, and 
Leu-4) or the mature monocyte specific antigen, Leu-M3.  Unlike most freshly 
isolated Leu-11+ human NK cells, the MLR-activated Leu-11+ cells expressed 
class II major histocompatability antigens, DR and DC. Concomitant with expres- 
sion of class II gene products, the Leu-11 +,DR+ NK cells demonstrate enhanced 
cytotoxicity against  the  NK-sensitive  tumor  cell  line  K562.  The  presence of 
mitotic cells in  the Leu-1 I+,DR+  population  and the acquisition of increased 
levels  of transferrin  receptor on  the  cell  surface  were  further  indicators  of 
activation  of  these  cells.  The  direct  precursors  of  the  MLR-activated  Leu- 
1 I+,DR+ cell were Leu-11+ cells that lacked expression of another NK-associ- 
ated antigen Leu-7, i.e., Leu-7-, 11 +. These studies provided a definitive iden- 
tification of the "NK-like" cell in MLR cultures and thus allow quantitation and 
isolation of these cells for further study. 
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